1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. GENFIT
  6. News
  7. Summary
    GNFT   FR0004163111

GENFIT

(GNFT)
  Report
Real-time Euronext Paris  -  05/23 11:35:10 am EDT
3.420 EUR   +0.83%
05/13European ADRs Move Higher in Friday Trading
MT
05/12European ADRs Decline in Thursday Trading
MT
05/11GENFIT Reports First Quarter 2022 Financial Information (Unaudited financial information under IFRS)
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Move Lower in Monday Trading

12/13/2021 | 11:14am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ATAI LIFE SCIENCES N.V. -3.25% 3.87 Delayed Quote.-47.58%
AUTOLUS THERAPEUTICS PLC -1.09% 2.71 Delayed Quote.-47.21%
AVADEL PHARMACEUTICALS PLC -4.17% 3.68 Delayed Quote.-52.48%
BICYCLE THERAPEUTICS PLC 0.12% 17.32 Delayed Quote.-71.58%
BIOFRONTERA AG 2.36% 1.085 Delayed Quote.-28.38%
BIONTECH SE 0.13% 163.22 Delayed Quote.-36.77%
CARNIVAL CORPORATION -0.15% 13.11 Delayed Quote.-34.74%
CRITEO S.A. -3.46% 25.7 Delayed Quote.-31.52%
GENFIT 0.83% 3.42 Real-time Quote.-21.41%
IDEX BIOMETRICS ASA -1.83% 1.237 Real-time Quote.-60.13%
IDEX CORPORATION 0.01% 185.5 Delayed Quote.-21.51%
LLOYDS BANKING GROUP PLC 1.61% 44.3 Delayed Quote.-8.79%
MEREO BIOPHARMA GROUP PLC -2.23% 0.521 Delayed Quote.-66.69%
MYT NETHERLANDS PARENT B.V. -1.75% 10.66 Delayed Quote.-48.84%
NAVIOS MARITIME HOLDINGS INC. -2.65% 3.3 End-of-day quote.-10.57%
NAVIOS MARITIME PARTNERS L.P. 4.95% 30.31 Delayed Quote.15.11%
RYANAIR HOLDINGS PLC 0.38% 14.355 Real-time Quote.-6.23%
VERONA PHARMA PLC 5.88% 4.14 Delayed Quote.-41.82%
All news about GENFIT
05/13European ADRs Move Higher in Friday Trading
MT
05/12European ADRs Decline in Thursday Trading
MT
05/11GENFIT Reports First Quarter 2022 Financial Information (Unaudited financial informatio..
GL
05/11GENFIT Reports First Quarter 2022 Financial Information (Unaudited financial informatio..
AQ
05/11GENFIT Reports Unaudited Revenue Results for the First Quarter Ended March 31, 2022
CI
05/11European ADRs Move Sharply Higher in Wednesday Trading
MT
05/11GENFIT : 1st quarter earnings
CO
05/10European ADRs Move Higher in Tuesday Trading
MT
05/02GENFIT Announces Publication of the 2021 Universal Registration Document; the 2021 Annu..
AQ
04/29GENFIT : Say-on-Pay Report (extract from 2021 Universal Registration Document)
PU
More news
Analyst Recommendations on GENFIT
More recommendations
Financials
Sales 2022 29,0 M 31,0 M 31,0 M
Net income 2022 -49,5 M -52,9 M -52,9 M
Net cash 2022 150 M 160 M 160 M
P/E ratio 2022 -4,79x
Yield 2022 -
Capitalization 170 M 182 M 182 M
EV / Sales 2022 0,70x
EV / Sales 2023 3,13x
Nbr of Employees 122
Free-Float 86,8%
Chart GENFIT
Duration : Period :
GENFIT Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENFIT
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 3,42 €
Average target price 10,48 €
Spread / Average Target 206%
EPS Revisions
Managers and Directors
Pascal Prigent CEO & EVP-Marketing & Development
Thomas Baetz Chief Financial Officer
Jean-François Mouney Chairman
Dean W. Hum Chief Scientific Officer
Carol L. Addy Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
GENFIT-21.41%178
MODERNA, INC.-46.35%54 195
LONZA GROUP AG-27.84%41 796
IQVIA HOLDINGS INC.-28.46%38 202
SEAGEN INC.-9.68%25 704
ICON PUBLIC LIMITED COMPANY-30.22%17 567